To The Administration
HLC letter expressing concerns over proposals to limit intellectual property protections for COVID-19 diagnostic tools and therapeutics under the World Trade Organization’s TRIPS agreement.
- Topics: Competition, Innovation, Medicare
Related Letters & Comments
HLC drives policy change through strategic letters, comments, and reports that promote private-sector innovation. Focused on priorities like Medicare reform, telehealth, and health equity, HLC engages with lawmakers and agencies to shape a smarter, more responsive healthcare system.
To Congress
HLC letter to Senate Finance Committee in advance of it’s hearing, “The Rising Cost of Healthcare: Considering Meaningful Solutions for All Americans.”
To The Administration
HLC comments support strengthening intellectual property provisions of USMACA
To The Administration
